Royal Life Sciences Private Limited, a active private limited company, was established on 15 April 1996 in Secunderabad, Telangana, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U51900TG1996PTC023799. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.20 M and a paid-up capital of ₹2.20 M.
Formerly known as Kerti Solutions Private Limited. It upholds a compliant status. Its leadership includes Dipender Singh (Managing Director), Chandpreet Singh Nishter (Director). Past directors included Akhil Priya Pandey, Surjit Kaur. It holds ₹8.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No-4, Second Floor, Sai Nagar Colony, Bsnl Lane, Picket, Secunderabad, Telangana, 500009.
U51900TG1996PTC023799
023799
15 April 1996
₹2.20 M
₹2.20 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Royal Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dipender Singh | Managing Director | 15 Apr 1996 | Current |
| Chandpreet Singh Nishter | Director | 30 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Jan 2025 | Past |
| Pramod Abcsdd | Director | 13 May 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Royal Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 275.9% increase. The company also saw a substantial improvement in profitability, with a 121.4% increase in profit. The company's net worth Soared by an impressive increase of 83.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Royal Life Sciences had a public holding of 18.28%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2003 | Syndicate Bank | ₹8.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Royal Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Royal Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Royal Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Chandpreet Singh Nishter was appointed as a Director was appointed as a Director on 30 Jan 2025 & has been associated with this company since 10 months 26 days . was documented.
Royal Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Royal Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity A charge with Syndicate Bank of Rs. 8.00 M registered on 18 Sep 2003 with Charge ID 90123171 was modified on 05 Jul 2019. was completed.
The activity A charge with Syndicate Bank amounted to Rs. 8.00 M with Charge ID 90123171 was registered on 18 Sep 2003. was completed.
The activity Dipender Singh was appointed as a Managing Director was appointed as a Managing Director on 15 Apr 1996 & has been associated with this company since 29 years 8 months . was completed.
The CIN of Royal Life Sciences Private Limited is U51900TG1996PTC023799.
Royal Life Sciences Private Limited is headquartered at Plot No-4, Second Floor, Sai Nagar Colony, Bsnl Lane, Picket, Secunderabad, Telangana, 500009.
Royal Life Sciences Private Limited was incorporated on 15 April 1996.
The current directors of Royal Life Sciences Private Limited are
The primary industry of Royal Life Sciences Private Limited is Professional, Scientific And Technical.
Royal Life Sciences Private Limited is unlisted.
The authorized capital of Royal Life Sciences Private Limited is ₹2.20 M, and the paid-up capital is ₹2.20 M.
The compliance status of Royal Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX